CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...